Dr. Kumar - Safety and Efficacy of Novel Combination Therapy with Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide in Newly Diagnosed Multiple Myeloma: Initial Results from the Phase I/II Multi-Center EVOLUTION Study
Shaji Kumar, MD Mayo Clinic Rochester, Minnesota USA
To view the video full screen, click on the small
button next to the volume control in the
lower right hand corner.